| Organization | CTAD 2026 Attendance |
|---|---|
UCB Brussels, Belgium | ◇Silver Sponsor |
Belgian biopharma developing bepranemab, an anti-tau antibody that completed a phase 2 trial in early Alzheimer's disease. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Instantly find 20 buyers from UCB
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction